Claire Danel

Université Claude Bernard Lyon 1 — France

Medicine · Health Sciences

55h-index10.7kcitations247works4.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(43), Medical Imaging and Pathology Studies(34), Lung Cancer Treatments and Mutations(31), Neonatal Respiratory Health Research(24), Lung Cancer Diagnosis and Treatment(21)

Publications247 total

MiR-193b-3p and miR-132-3p as prognostic biomarkers of survival in pleural mesothelioma patients treated with first-line bevacizumab plus pemetrexed-platinum chemotherapy in the IFCT-0701 MAPS phase 3 trial
Translational Oncology·2025· 4 citedOpen Access
VEGFR2 and CD34 expression associated with longer survival in patients with pleural mesothelioma in the IFCT-GFPC-0701 MAPS phase 3 trial
Lung Cancer·2023· 2 citedOpen Access
Low miR-155, -29c, -132 or -100 predicts longer survival with bevacizumab plus chemotherapy in patients with pleural mesothelioma from MAPS trial
SPIRE - Sciences Po Institutional REpository·2023
Paraneoplastic pemphigus uncovers distinct clinical and biological phenotypes of western unicentric Castleman disease
British Journal of Haematology·2023· 17 citedOpen Access
A defect of amphiregulin release predicted longer survival independently of <scp>YAP</scp> expression in patients with pleural mesothelioma in the <scp>IFCT</scp>‐0701 <scp>MAPS</scp> phase 3 trial
International Journal of Cancer·2022· 5 citedOpen Access
A role for IL-33–activated ILC2s in eosinophilic vasculitis
JCI Insight·2021· 30 citedOpen Access
Cytosolic amphiregulin accumulation in malignant pleural mesothelioma cells predicts better survival of patient from the IFCT-GFPC-0701 MAPS Phase 3 trial
HAL (Le Centre pour la Communication Scientifique Directe)·2019
L’expression cytosolique tumorale d’amphiréguline prédit la meilleure survie des patients atteints de mésothéliome pleural malin : analyses chez 288 patients de la cohorte Bio-MAPS
Morphologie·2019
P2.09-17 Real-World Concordance Across Pathologists for PD-L1 Scoring in Non-Small Cell Lung Cancer: Results from a Large Nationwide Initiative
Journal of Thoracic Oncology·2019· 11 citedOpen Access
Bronchodilation induced by PGE<sub>2</sub> is impaired in Group III pulmonary hypertension
British Journal of Pharmacology·2019· 14 citedOpen Access
Clinicopathological and Molecular Study of Peritoneal Carcinomatosis Associated with Non-Small Cell Lung Carcinoma
Pathology & Oncology Research·2019· 10 cited
<i>NF1</i> mutations identify molecular and clinical subtypes of lung adenocarcinomas
Cancer Medicine·2019· 18 citedOpen Access
L’expression cytosolique tumorale d’amphireguline prédit la meilleure survie des patients atteints de mésothéliome pleural malin : analyses chez 288 patients de la cohorte Bio-MAPS.
HAL (Le Centre pour la Communication Scientifique Directe)·2019
Shorter Survival in Malignant Pleural Mesothelioma Patients With High PD-L1 Expression Associated With Sarcomatoid or Biphasic Histology Subtype: A Series of 214 Cases From the Bio-MAPS Cohort
Clinical Lung Cancer·2019· 63 citedOpen Access
Association of TP53 mutations with response and longer survival under immune checkpoint inhibitors in advanced non-small-cell lung cancer
Lung Cancer·2019· 166 citedOpen Access
L’expression cytosolique tumorale d’amphireguline prédit la meilleure survie des patients atteints de mésothéliome pleural malin : analyses chez 288 patients de la cohorte Bio-MAPS.
HAL (Le Centre pour la Communication Scientifique Directe)·2019
Pulmonary Arterial Histologic Lesions in Patients With COPD With Severe Pulmonary Hypertension
CHEST Journal·2019· 58 citedOpen Access
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial
British Journal of Cancer·2019· 23 citedOpen Access
C4d detection and histological patterns in the diagnosis of antibody‐mediated rejection after lung transplantation: a single‐centre study
Histopathology·2019· 11 cited
Safe and effective use of nivolumab for treating lung adenocarcinoma associated with sporadic lymphangioleiomyomatosis: a rare case report
BMC Pulmonary Medicine·2019· 7 citedOpen Access
page 1 of 13Next →

Frequent Co-authors

Marc Riquet(9), Ronald G. Crystal(8), Melissa A. Rosenfeld(5), Dominique Israël‐Biet(5), Françoise Le Pimpec‐Barthes(5), Howard Jaffe(4), M. Stern(4), Aurélie Cazes(4), Antoine M. Dujon(4), Dominique Valeyre(4), Hélène Blons(4), Pierre Laurent‐Puig(4), Wolf H. Fridman(3), Noel G. McElvaney(3), Andrea Mastrangeli(3), John G. Hay(3), Yasuhiro Setoguchi(3), Leslie D. Stratford-Perricaudet(3), Michel Perricaudet(3), Andréa Pavirani(3)